Page 22 - கட்டுப்படுத்தப்படுகிறது மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Levitee Labs Inc. (the “Company” or “Levitee”) is pleased to announce that it has received final approval from the Canadian Securities Exchange (“CSE”) to list its common shares on the CSE. Levitee Labs Inc. (the “Company” or “Levitee”) is pleased to announce that it has received final approval from the Canadian Securities Exchange (“CSE”) to list its common shares on the CSE. At the opening of the market on July 21, the common shares of Levitee will begin trading under the ticker symbol “LVT”. Please see https://thecse.com/en/listings/life-sciences/levitee-labs-inc for more information. Levitee is a functional mushrooms company focused on the development and sale of high potency mushroom extract nutraceuticals and supplies and equipment for mushroom cultivation. The Levitee leadership team is composed of diverse and complementary skillsets, deriving from past successes in entrepreneurship, clinical research, venture capital, M&A, operations, techn

United statesUnited kingdomPouya farmandEarth circle organics incBc ltdHealth canadaCanadian securities exchangePhytoceuticals ltdLevitee labs incLevitee labsSporeo supplyBritish columbiaCircle organics incControlled drugsSubstances actChief executive officer